Avadel Pharmaceuticals plc ADR buy BiotechBee
Start price
17.07.23
/
70%
€13.60
Target price
31.12.25
€23.00
Performance (%)
11.03%
End price
14.12.24
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 11.03%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | - | - | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
According to BiotechBee what are the pros and cons of Avadel Pharmaceuticals plc ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avadel Pharmaceuticals plc ADR diskutieren
Buy mit Kursziel 23,0
In the thread Trading Avadel Pharmaceuticals plc ADR
Buy beendet

